What is Aspire BioPharma, Inc. (ASBP) stock price today?

Aspire BioPharma, Inc. (ASBP) currently trades at $0.22 per share. The stock has a market capitalization of $1.23M and a P/E ratio of —x.

Is ASBP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Aspire BioPharma, Inc. has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Aspire BioPharma, Inc.'s revenue and earnings?

Aspire BioPharma, Inc. has trailing twelve-month (TTM) revenue of $6200.00 with profit margins of 0.00%. Earnings per share (EPS) is $-16.38.

ASBP

Aspire BioPharma, Inc.

NASDAQ: ASBP · HEALTHCARE · BIOTECHNOLOGY

$0.22

-9.30% today

Updated 2026-04-30

Market cap

$1.23M

P/E ratio

—

P/S ratio

197.66x

EPS (TTM)

$-16.38

Dividend yield

—

52W range

$0 – $35

Volume

12.1M

Market cap

$1.23M

P/E ratio

—

P/S ratio

197.66x

EPS (TTM)

$-16.38

Dividend yield

—

52W range

$0 – $35

Volume

12.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-927841.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$6202.00	$6200.00
Net income	$3.34M	$4.46M	$-12.54M	$-24.48M	$-4.71M
EPS	—	—	—	—	$-16.38
Free cash flow	$-1.41M	$-653110.00	$-265186.00	$-4.92M	$-927841.00
Profit margin	—	—	—	-394,725.06%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ASBP	$1.23M	16	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Aspire BioPharma, Inc. trades at $0.22. Our Smart Value Score of 16/100 indicates the stock is weak. TTM revenue stands at $6200.00.

Frequently asked questions

What is Aspire BioPharma, Inc.'s stock price?

Aspire BioPharma, Inc. (ASBP) trades at $0.22.

Is Aspire BioPharma, Inc. overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Aspire BioPharma, Inc. (ASBP)?

The analyst target price is $—, representing NaN% downside from the current price of $0.22.

What is Aspire BioPharma, Inc.'s revenue?

TTM revenue is $6200.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

aspirebiolabs.com

Quick metrics

P/S ratio197.66x

ROE—

Beta1.00

50D MA$0.95

200D MA$8.05

Shares out0.01B

Float0.00B

Short ratio—

Avg volume12.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ASBP vs LLY →ASBP vs JNJ →ASBP vs ABBV →Stock screener →